The Heart and COVID-19: What Cardiologists Need to Know

Arq Bras Cardiol. 2020 May 11;114(5):805-816. doi: 10.36660/abc.20200279.
[Article in English, Portuguese]

Abstract
in English, Portuguese

In face of the pandemic of the novel coronavirus disease 2019 (COVID-19), the management of patients with cardiovascular risk factors and/or disease is challenging. The cardiovascular complications evidenced in patients with COVID-19 derive from several mechanisms, ranging from direct viral injury to complications secondary to the inflammatory and thrombotic responses to the infection. The proper care of patients with COVID-19 requires special attention to the cardiovascular system aimed at better outcomes.

Frente à pandemia da doença causada pelo novo coronavírus (COVID-19), o manejo do paciente com fator de risco e/ou doença cardiovascular é desafiador nos dias de hoje. As complicações cardiovasculares evidenciadas nos pacientes com COVID-19 resultam de vários mecanismos, que vão desde lesão direta pelo vírus até complicações secundárias à resposta inflamatória e trombótica desencadeada pela infecção. O cuidado adequado do paciente com COVID-19 exige atenção ao sistema cardiovascular em busca de melhores desfechos.

Publication types

  • Review

MeSH terms

  • Betacoronavirus*
  • COVID-19
  • Cardiopulmonary Resuscitation / standards
  • Cardiovascular Diseases / diagnosis
  • Cardiovascular Diseases / therapy
  • Cardiovascular Diseases / virology*
  • Cardiovascular Physiological Phenomena
  • Coronavirus Infections / complications*
  • Coronavirus Infections / diagnosis
  • Coronavirus Infections / therapy
  • Health Personnel* / standards
  • Heart / physiopathology
  • Humans
  • Pandemics
  • Patient Care / standards
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / therapy
  • Practice Guidelines as Topic
  • Risk Factors
  • SARS-CoV-2
  • Ventricular Dysfunction / etiology